Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Viral Cardiac Infections

  • Chapter
  • First Online:
Viral Infections in Children, Volume II

  • 526 Accesses

Abstract

Viral infections can affect the pediatric heart in a multitude of ways. The two most common viral cardiac processes are myocarditis and pericarditis. Numerous viruses have been implicated in these disease states. In addition to direct viral effects on the myocardium and pericardium, inflammatory mediators also play a role in these conditions. A high index of suspicion, thorough history and physical examination, along with directed laboratory testing, electrocardiography and echocardiography are necessary for the diagnosis and management of myocarditis and pericarditis. Occasionally, more advanced studies such as magnetic resonance imaging (MRI) and endomyocardial biopsy may be useful. Finally, human immunodeficiency virus (HIV) can have a number of cardiac related effects. Children with HIV, require routine cardiac monitoring and counseling.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation. 1996;93(5):841–2.

    Article  CAS  PubMed  Google Scholar 

  2. Imazio M. Contemporary management of pericardial diseases. Curr Opin Cardiol. 2012;27(3):308–17.

    Article  PubMed  Google Scholar 

  3. Kyto V, Saraste A, Voipio-Pulkki LM, Saukko P. Incidence of fatal myocarditis: a population-based study in Finland. Am J Epidemiol. 2007;165(5):570–4.

    Article  PubMed  Google Scholar 

  4. Weber MA, Ashworth MT, Risdon RA, Malone M, Burch M, Sebire NJ. Clinicopathological features of paediatric deaths due to myocarditis: an autopsy series. Arch Dis Child. 2008;93(7):594–8.

    Article  CAS  PubMed  Google Scholar 

  5. Doolan A, Langlois N, Semsarian C. Causes of sudden cardiac death in young Australians. Med J Aust. 2004;180(3):110–2.

    PubMed  Google Scholar 

  6. Puranik R, Chow CK, Duflou JA, Kilborn MJ, McGuire MA. Sudden death in the young. Heart Rhythm. 2005;2(12):1277–82.

    Article  PubMed  Google Scholar 

  7. Ghelani SJ, Spaeder MC, Pastor W, Spurney CF, Klugman D. Demographics, trends, and outcomes in pediatric acute myocarditis in the United States, 2006 to 2011. Circ Cardiovasc Qual Outcomes. 2012;5(5):622–7.

    Article  PubMed  Google Scholar 

  8. Kyto V, Sipila J, Rautava P. The effects of gender and age on occurrence of clinically suspected myocarditis in adulthood. Heart. 2013;99(22):1681–4.

    Article  PubMed  Google Scholar 

  9. Fairweather D, Cooper Jr LT, Blauwet LA. Sex and gender differences in myocarditis and dilated cardiomyopathy. Curr Probl Cardiol. 2013;38(1):7–46.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Huber SA, Job LP, Auld KR. Influence of sex hormones on coxsackie B-3 virus infection in Balb/c mice. Cell Immunol. 1982;67(1):173–9.

    Article  CAS  PubMed  Google Scholar 

  11. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, Klingel K, Kandolf R, Sechtem U. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation. 2006;114(15):1581–90.

    Article  PubMed  Google Scholar 

  12. Pankuweit S, Moll R, Baandrup U, Portig I, Hufnagel G, Maisch B. Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. Hum Pathol. 2003;34(5):497–503.

    Article  PubMed  Google Scholar 

  13. Martin AB, Webber S, Fricker FJ, Jaffe R, Demmler G, Kearney D, Zhang YH, Bodurtha J, Gelb B, Ni J, et al. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation. 1994;90(1):330–9.

    Article  CAS  PubMed  Google Scholar 

  14. Kashimura T, Kodama M, Hotta Y, Hosoya J, Yoshida K, Ozawa T, Watanabe R, Okura Y, Kato K, Hanawa H, Kuwano R, Aizawa Y. Spatiotemporal changes of coxsackievirus and adenovirus receptor in rat hearts during postnatal development and in cultured cardiomyocytes of neonatal rat. Virchows Arch. 2004;444(3):283–92.

    Article  CAS  PubMed  Google Scholar 

  15. Camargo PR, Okay TS, Yamamoto L, Del Negro GM, Lopes AA. Myocarditis in children and detection of viruses in myocardial tissue: implications for immunosuppressive therapy. Int J Cardiol. 2011;148(2):204–8.

    Article  PubMed  Google Scholar 

  16. Baruteau AE, Boimond N, Ramful D. Myocarditis associated with 2009 influenza A (H1N1) virus in children. Cardiol Young. 2010;20(3):351–2.

    Article  PubMed  Google Scholar 

  17. Randolph AG, Vaughn F, Sullivan R, Rubinson L, Thompson BT, Yoon G, Smoot E, Rice TW, Loftis LL, Helfaer M, Doctor A, Paden M, Flori H, Babbitt C, Graciano AL, Gedeit R, Sanders RC, Giuliano JS, Zimmerman J, Uyeki TM; Pediatric Acute Lung Injury and Sepsis Investigator’s Network and the National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Critically ill children during the 2009-2010 influenza pandemic in the United States. Pediatrics. 2011;128(6):e1450–8.

    Google Scholar 

  18. Andreoletti L, Leveque N, Boulagnon C, Brasselet C, Fornes P. Viral causes of human myocarditis. Arch Cardiovasc Dis. 2009;102(6–7):559–68.

    Article  PubMed  Google Scholar 

  19. Premkumar M, Rangegowda D, Vashishtha C, Bhatia V, Khumuckham JS, Kumar B. Acute viral hepatitis e is associated with the development of myocarditis. Case Reports Hepatol. 2015;2015:458056.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, Klingel K, Kandolf R, Sechtem U, Cooper LT, Bohm M. Update on myocarditis. J Am Coll Cardiol. 2012;59(9):779–92.

    Article  PubMed  Google Scholar 

  21. Rohayem J, Dinger J, Fischer R, Klingel K, Kandolf R, Rethwilm A. Fatal myocarditis associated with acute parvovirus B19 and human herpesvirus 6 coinfection. J Clin Microbiol. 2001;39(12):4585–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Simpson KE, Storch GA, Lee CK, Ward KE, Danon S, Simon CM, Delaney JW, Tong A, Canter CE. High frequency of detection by PCR of viral nucleic acid in the blood of infants presenting with clinical myocarditis. Pediatr Cardiol. 2016;37(2):399–404.

    Article  PubMed  Google Scholar 

  23. Dec Jr GW, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DC, Johnson RA. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med. 1985;312(14):885–90.

    Article  PubMed  Google Scholar 

  24. Ni J, Bowles NE, Kim YH, Demmler G, Kearney D, Bricker JT, Towbin JA. Viral infection of the myocardium in endocardial fibroelastosis. Molecular evidence for the role of mumps virus as an etiologic agent. Circulation. 1997;95(1):133–9.

    Article  CAS  PubMed  Google Scholar 

  25. Saphir O, Field M. Complications of myocarditis in children. J Pediatr. 1954;45(4):457–63.

    Article  CAS  PubMed  Google Scholar 

  26. Woodruff JF. Viral myocarditis. A review. Am J Pathol. 1980;101(2):425–84.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Esfandiarei M, McManus BM. Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol. 2008;3:127–55.

    Article  CAS  PubMed  Google Scholar 

  28. Coyne CB, Bergelson JM. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell. 2006;124(1):119–31.

    Article  CAS  PubMed  Google Scholar 

  29. Noutsias M, Fechner H, de Jonge H, Wang X, Dekkers D, Houtsmuller AB, Pauschinger M, Bergelson J, Warraich R, Yacoub M, Hetzer R, Lamers J, Schultheiss HP, Poller W. Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections. Circulation. 2001;104(3):275–80.

    Article  CAS  PubMed  Google Scholar 

  30. Godeny EK, Gauntt CJ. Murine natural killer cells limit coxsackievirus B3 replication. J Immunol. 1987;139(3):913–8.

    CAS  PubMed  Google Scholar 

  31. Henke A, Huber S, Stelzner A, Whitton JL. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol. 1995;69(11):6720–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Hayder H, Mullbacher A. Molecular basis of immune evasion strategies by adenoviruses. Immunol Cell Biol. 1996;74(6):504–12.

    Article  CAS  PubMed  Google Scholar 

  33. Tavares PS, Rocon-Albuquerque Jr R, Leite-Moreira AF. Innate immune receptor activation in viral myocarditis: pathophysiologic implications. Rev Port Cardiol. 2010;29(1):57–78.

    PubMed  Google Scholar 

  34. Yamada T, Matsumori A, Sasayama S. Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation. 1994;89(2):846–51.

    Article  CAS  PubMed  Google Scholar 

  35. Kishimoto C, Kuroki Y, Hiraoka Y, Ochiai H, Kurokawa M, Sasayama S. Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage. Circulation. 1994;89(6):2836–42.

    Article  CAS  PubMed  Google Scholar 

  36. Shioi T, Matsumori A, Nishio R, Ono K, Kakio T, Sasayama S. Protective role of interleukin-12 in viral myocarditis. J Mol Cell Cardiol. 1997;29(9):2327–34.

    Article  CAS  PubMed  Google Scholar 

  37. Sole MJ, Liu P. Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy. J Am Coll Cardiol. 1993;22(4 Suppl A):99A–105A.

    Article  CAS  PubMed  Google Scholar 

  38. Li Y, Heuser JS, Cunningham LC, Kosanke SD, Cunningham MW. Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J Immunol. 2006;177(11):8234–40.

    Article  CAS  PubMed  Google Scholar 

  39. Caforio AL, Tona F, Bottaro S, Vinci A, Dequal G, Daliento L, Thiene G, Iliceto S. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity. 2008;41(1):35–45.

    Article  CAS  PubMed  Google Scholar 

  40. Mascaro-Blanco A, Alvarez K, Yu X, Lindenfeld J, Olansky L, Lyons T, Duvall D, Heuser JS, Gosmanova A, Rubenstein CJ, Cooper LT, Kem DC, Cunningham MW. Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies. Autoimmunity. 2008;41(6):442–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Huber SA. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice. Lab Invest. 1997;76(5):691–701.

    CAS  PubMed  Google Scholar 

  42. Saito S, Hiroi Y, Zou Y, Aikawa R, Toko H, Shibasaki F, Yazaki Y, Nagai R, Komuro I. beta-Adrenergic pathway induces apoptosis through calcineurin activation in cardiac myocytes. J Biol Chem. 2000;275(44):34528–33.

    Article  CAS  PubMed  Google Scholar 

  43. Shizukuda Y, Buttrick PM, Geenen DL, Borczuk AC, Kitsis RN, Sonnenblick EH. beta-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol. 1998;275(3 Pt 2):H961–8.

    CAS  PubMed  Google Scholar 

  44. Baba A, Yoshikawa T, Ogawa S. Autoantibodies produced against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2002;40(6):1153–9.

    Article  CAS  PubMed  Google Scholar 

  45. Caforio AL, Bonifacio E, Stewart JT, Neglia D, Parodi O, Bottazzo GF, McKenna WJ. Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol. 1990;15(7):1527–34.

    Article  CAS  PubMed  Google Scholar 

  46. Caforio AL, Goldman JH, Haven AJ, Baig KM, Libera LD, McKenna WJ. Circulating cardiac-specific autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis. The Myocarditis Treatment Trial Investigators. Eur Heart J. 1997;18(2):270–5.

    Article  CAS  PubMed  Google Scholar 

  47. Lee EY, Lee HL, Kim HT, Lee HD, Park JA. Clinical features and short-term outcomes of pediatric acute fulminant myocarditis in a single center. Korean J Pediatr. 2014;57(11):489–95.

    Article  PubMed  PubMed Central  Google Scholar 

  48. English RF, Janosky JE, Ettedgui JA, Webber SA. Outcomes for children with acute myocarditis. Cardiol Young. 2004;14(5):488–93.

    Article  PubMed  Google Scholar 

  49. Freedman SB, Haladyn JK, Floh A, Kirsh JA, Taylor G, Thull-Freedman J. Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation. Pediatrics. 2007;120(6):1278–85.

    Article  PubMed  Google Scholar 

  50. Kim HJ, Yoo GH, Kil HR. Clinical outcome of acute myocarditis in children according to treatment modalities. Korean J Pediatr. 2010;53(7):745–52.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Canter CE, Simpson KP. Diagnosis and treatment of myocarditis in children in the current era. Circulation. 2014;129(1):115–28.

    Article  PubMed  Google Scholar 

  52. Lieberman EB, Hutchins GM, Herskowitz A, Rose NR, Baughman KL. Clinicopathologic description of myocarditis. J Am Coll Cardiol. 1991;18(7):1617–26.

    Article  CAS  PubMed  Google Scholar 

  53. Cooper Jr LT. Acute heart failure due to fulminant and giant cell myocarditis. Herz. 2006;31(8):767–70.

    Article  PubMed  Google Scholar 

  54. Gupta S, Markham DW, Drazner MH, Mammen PP. Fulminant myocarditis. Nat Clin Pract Cardiovasc Med. 2008;5(11):693–706.

    Article  PubMed  Google Scholar 

  55. Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation. 2006;113(6):876–90.

    Article  PubMed  Google Scholar 

  56. Felker GM, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Baughman KL, Hare JM. Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol. 2000;36(1):227–32.

    Article  CAS  PubMed  Google Scholar 

  57. Sankar J, Khalil S, Jeeva Sankar M, Kumar D, Dubey N. Short-term outcomes of acute fulminant myocarditis in children. Pediatr Cardiol. 2011;32(7):885–90.

    Article  PubMed  Google Scholar 

  58. Teele SA, Allan CK, Laussen PC, Newburger JW, Gauvreau K, Thiagarajan RR. Management and outcomes in pediatric patients presenting with acute fulminant myocarditis. J Pediatr. 2011;158(4):638–43.e631.

    Google Scholar 

  59. Rajs J, Hammarquist F. Sudden infant death in Stockholm. A forensic pathology study covering ten years. Acta Paediatr Scand. 1988;77(6):812–20.

    Article  CAS  PubMed  Google Scholar 

  60. Dettmeyer R, Baasner A, Schlamann M, Padosch SA, Haag C, Kandolf R, Madea B. Role of virus-induced myocardial affections in sudden infant death syndrome: a prospective postmortem study. Pediatr Res. 2004;55(6):947–52.

    Article  PubMed  Google Scholar 

  61. Harmon KG, Drezner JA, Maleszewski JJ, Lopez-Anderson M, Owens D, Prutkin JM, Asif IM, Klossner D, Ackerman MJ. Pathogeneses of sudden cardiac death in national collegiate athletic association athletes. Circ Arrhythm Electrophysiol. 2014;7(2):198–204.

    Article  PubMed  Google Scholar 

  62. Maron BJ, Spirito P, Ackerman MJ, Casey SA, Semsarian C, Estes 3rd NA, Shannon KM, Ashley EA, Day SM, Pacileo G, Formisano F, Devoto E, Anastasakis A, Bos JM, Woo A, Autore C, Pass RH, Boriani G, Garberich RF, Almquist AK, Russell MW, Boni L, Berger S, Maron MS, Link MS. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2013;61(14):1527–35.

    Article  PubMed  Google Scholar 

  63. Suarez-Mier MP, Aguilera B, Mosquera RM, Sanchez-de-Leon MS. Pathology of sudden death during recreational sports in Spain. Forensic Sci Int. 2013;226(1–3):188–96.

    Article  PubMed  Google Scholar 

  64. Durani Y, Egan M, Baffa J, Selbst SM, Nager AL. Pediatric myocarditis: presenting clinical characteristics. Am J Emerg Med. 2009;27(8):942–7.

    Article  PubMed  Google Scholar 

  65. May LJ, Patton DJ, Fruitman DS. The evolving approach to paediatric myocarditis: a review of the current literature. Cardiol Young. 2011;21(3):241–51.

    Article  PubMed  Google Scholar 

  66. Sachdeva S, Song X, Dham N, Heath DM, DeBiasi RL. Analysis of clinical parameters and cardiac magnetic resonance imaging as predictors of outcome in pediatric myocarditis. Am J Cardiol. 2015;115(4):499–504.

    Article  PubMed  Google Scholar 

  67. Shekerdemian L, Bohn D. Acute viral myocarditis: epidemiology and pathophysiology. Pediatr Crit Care Med. 2006;7(6):S2–7.

    Article  Google Scholar 

  68. Daubeney PE, Nugent AW, Chondros P, Carlin JB, Colan SD, Cheung M, Davis AM, Chow CW, Weintraub RG; National Australian Childhood Cardiomyopathy Study. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation. 2006;114(24):2671–8.

    Google Scholar 

  69. Ichikawa R, Sumitomo N, Komori A, Abe Y, Nakamura T, Fukuhara J, Matsumura M, Miyashita M, Kanamaru H, Ayusawa M, Mugishima H. The follow-up evaluation of electrocardiogram and arrhythmias in children with fulminant myocarditis. Circ J. 2011;75(4):932–8.

    Article  PubMed  Google Scholar 

  70. Andrews RE, Fenton MJ, Ridout DA, Burch M, British Congenital Cardiac A. New-onset heart failure due to heart muscle disease in childhood: a prospective study in the United Kingdom and Ireland. Circulation. 2008;117(1):79–84.

    Article  PubMed  Google Scholar 

  71. Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, Lurie PR, McCoy KL, McDonald MA, Messere JE, Colan SD. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003;348(17):1647–55.

    Article  PubMed  Google Scholar 

  72. Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, Messere J, Cox GF, Lurie PR, Hsu D, Canter C, Wilkinson JD, Lipshultz SE. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006;296(15):1867–76.

    Article  CAS  PubMed  Google Scholar 

  73. Blauwet LA, Cooper LT. Myocarditis. Prog Cardiovasc Dis. 2010;52(4):274–88.

    Article  PubMed  Google Scholar 

  74. Mendes LA, Dec GW, Picard MH, Palacios IF, Newell J, Davidoff R. Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am Heart J. 1994;128(2):301–7.

    Article  CAS  PubMed  Google Scholar 

  75. Khoo NS, Smallhorn JF, Atallah J, Kaneko S, Mackie AS, Paterson I. Altered left ventricular tissue velocities, deformation and twist in children and young adults with acute myocarditis and normal ejection fraction. J Am Soc Echocardiogr. 2012;25(3):294–303.

    Article  PubMed  Google Scholar 

  76. Escher F, Westermann D, Gaub R, Pronk J, Bock T, Al-Saadi N, Kuhl U, Schultheiss HP, Tschope C. Development of diastolic heart failure in a 6-year follow-up study in patients after acute myocarditis. Heart. 2011;97(9):709–14.

    Article  PubMed  Google Scholar 

  77. Kuhl U, Pauschinger M, Bock T, Klingel K, Schwimmbeck CP, Seeberg B, Krautwurm L, Poller W, Schultheiss HP, Kandolf R. Parvovirus B19 infection mimicking acute myocardial infarction. Circulation. 2003;108(8):945–50.

    Article  PubMed  CAS  Google Scholar 

  78. Sagar S, Liu PP, Cooper Jr LT. Myocarditis. Lancet. 2012;379(9817):738–47.

    Article  PubMed  Google Scholar 

  79. Sarda L, Colin P, Boccara F, Daou D, Lebtahi R, Faraggi M, Nguyen C, Cohen A, Slama MS, Steg PG, Le Guludec D. Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. J Am Coll Cardiol. 2001;37(3):786–92.

    Article  CAS  PubMed  Google Scholar 

  80. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E; Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized Protocols. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson. 2008;10:35.

    Google Scholar 

  81. Kim RJ, Shah DJ. Fundamental concepts in myocardial viability assessment revisited: when knowing how much is “alive” is not enough. Heart. 2004;90(2):137–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Pattynama PM, De Roos A, Van der Wall EE, Van Voorthuisen AE. Evaluation of cardiac function with magnetic resonance imaging. Am Heart J. 1994;128(3):595–607.

    Article  CAS  PubMed  Google Scholar 

  83. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol. 2009;53(17):1475–87.

    Google Scholar 

  84. Abdel-Aty H, Boye P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D, Bock P, Dietz R, Friedrich MG, Schulz-Menger J. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol. 2005;45(11):1815–22.

    Article  PubMed  Google Scholar 

  85. Aletras AH, Kellman P, Derbyshire JA, Arai AE. ACUT2E TSE-SSFP: a hybrid method for T2-weighted imaging of edema in the heart. Magn Reson Med. 2008;59(2):229–35.

    Article  PubMed  Google Scholar 

  86. Liu PP, Yan AT. Cardiovascular magnetic resonance for the diagnosis of acute myocarditis: prospects for detecting myocardial inflammation. J Am Coll Cardiol. 2005;45(11):1823–5.

    Article  PubMed  Google Scholar 

  87. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001;218(1):215–23.

    Article  CAS  PubMed  Google Scholar 

  88. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, Fritz P, Klingel K, Kandolf R, Sechtem U. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;109(10):1250–8.

    Article  PubMed  Google Scholar 

  89. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio Jr JJ, Olsen EG, Schoen FJ. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol. 1987;1(1):3–14.

    CAS  PubMed  Google Scholar 

  90. Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc. 1989;64(10):1235–45.

    Article  CAS  PubMed  Google Scholar 

  91. Wu LA, Lapeyre 3rd AC, Cooper LT. Current role of endomyocardial biopsy in the management of dilated cardiomyopathy and myocarditis. Mayo Clin Proc. 2001;76(10):1030–8.

    Article  CAS  PubMed  Google Scholar 

  92. Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation. 2006;113(4):593–5.

    Article  PubMed  Google Scholar 

  93. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula J, Starling RC, Towbin J, Virmani R; American Heart Association; American College of Cardiology; European Society of Cardiology. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation. 2007;116(19):2216–33.

    Google Scholar 

  94. Herskowitz A, Ahmed-Ansari A, Neumann DA, Beschorner WE, Rose NR, Soule LM, Burek CL, Sell KW, Baughman KL. Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis. J Am Coll Cardiol. 1990;15(3):624–32.

    Article  CAS  PubMed  Google Scholar 

  95. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, Zembala M, Polonski L, Rozek MM, Wodniecki J. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation. 2001;104(1):39–45.

    Article  CAS  PubMed  Google Scholar 

  96. Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation. 2003;107(6):857–63.

    Article  PubMed  Google Scholar 

  97. Klugman D, Berger JT, Sable CA, He J, Khandelwal SG, Slonim AD. Pediatric patients hospitalized with myocarditis: a multi-institutional analysis. Pediatr Cardiol. 2010;31(2):222–8.

    Article  PubMed  Google Scholar 

  98. Maisch B, Pankuweit S. Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives. Heart Fail Rev. 2013;18(6):761–95.

    Article  CAS  PubMed  Google Scholar 

  99. Kuhl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation. 2005;112(13):1965–70.

    Article  PubMed  Google Scholar 

  100. Friedman RA, Kearney DL, Moak JP, Fenrich AL, Perry JC. Persistence of ventricular arrhythmia after resolution of occult myocarditis in children and young adults. J Am Coll Cardiol. 1994;24(3):780–3.

    Article  CAS  PubMed  Google Scholar 

  101. Frustaci A, Chimenti C. Immunosuppressive therapy in myocarditis. Circ J. 2015;79(1):4–7.

    Article  PubMed  Google Scholar 

  102. Mason JW, O’Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med. 1995;333(5):269–75.

    Article  CAS  PubMed  Google Scholar 

  103. Drucker NA, Colan SD, Lewis AB, Beiser AS, Wessel DL, Takahashi M, Baker AL, Perez-Atayde AR, Newburger JW. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation. 1994;89(1):252–7.

    Article  CAS  PubMed  Google Scholar 

  104. McNamara DM, Holubkov R, Starling RC, Dec GW, Loh E, Torre-Amione G, Gass A, Janosko K, Tokarczyk T, Kessler P, Mann DL, Feldman AM. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation. 2001;103(18):2254–9.

    Article  CAS  PubMed  Google Scholar 

  105. Meune C, Spaulding C, Mahe I, Lebon P, Bergmann JF. Risks versus benefits of NSAIDs including aspirin in myocarditis: a review of the evidence from animal studies. Drug Saf. 2003;26(13):975–81.

    Article  CAS  PubMed  Google Scholar 

  106. Canter CE, Shaddy RE, Bernstein D, Hsu DT, Chrisant MR, Kirklin JK, Kanter KR, Higgins RS, Blume ED, Rosenthal DN, Boucek MM, Uzark KC, Friedman AH, Young JK; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Nursing; American Heart Association Council on Cardiovascular Surgery and Anesthesia; Quality of Care and Outcomes Research Interdisciplinary Working Group. Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;115(5):658–76.

    Google Scholar 

  107. Shirali GS, Ni J, Chinnock RE, Johnston JK, Rosenthal GL, Bowles NE, Towbin JA. Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med. 2001;344(20):1498–503.

    Article  CAS  PubMed  Google Scholar 

  108. Pietra BA, Kantor PF, Bartlett HL, Chin C, Canter CE, Larsen RL, Edens RE, Colan SD, Towbin JA, Lipshultz SE, Kirklin JK, Naftel DC, Hsu DT. Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy. Circulation. 2012;126(9):1079–86.

    Article  PubMed  PubMed Central  Google Scholar 

  109. Garbern JC, Gauvreau K, Blume ED, Singh TP. Is myocarditis an independent risk factor for post-transplant mortality in pediatric heart transplant recipients? Circ Heart Fail. 2016;9(1):e002328.

    Article  PubMed  Google Scholar 

  110. Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NAM, Cooper LT, Link MS, Maron MS. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis. Circulation. 2015;132(22):e273–80.

    Article  PubMed  Google Scholar 

  111. Lange RA, Hillis LD. Clinical practice. Acute pericarditis. N Engl J Med. 2004;351(21):2195–202.

    Article  CAS  PubMed  Google Scholar 

  112. Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH; Task Force on the Diagnosis and Management of Pricardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J. 2004;25(7):587–610.

    Google Scholar 

  113. Troughton RW, Asher CR, Klein AL. Pericarditis. Lancet. 2004;363(9410):717–27.

    Article  PubMed  Google Scholar 

  114. Geggel RL. Conditions leading to pediatric cardiology consultation in a tertiary academic hospital. Pediatrics. 2004;114(4):e409–17.

    Article  PubMed  Google Scholar 

  115. Ratnapalan S, Brown K, Benson L. Children presenting with acute pericarditis to the emergency department. Pediatr Emerg Care. 2011;27(7):581–5.

    Article  PubMed  Google Scholar 

  116. Permanyer-Miralda G, Sagrista-Sauleda J, Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients. Am J Cardiol. 1985;56(10):623–30.

    Article  CAS  PubMed  Google Scholar 

  117. Levy PY, Corey R, Berger P, Habib G, Bonnet JL, Levy S, Messana T, Djiane P, Frances Y, Botta C, DeMicco P, Dumon H, Mundler O, Chomel JJ, Raoult D. Etiologic diagnosis of 204 pericardial effusions. Medicine (Baltimore). 2003;82(6):385–91.

    Article  Google Scholar 

  118. Dery P, Marks MI, Shapera R. Clinical manifestations of coxsackievirus infections in children. Am J Dis Child. 1974;128(4):464–8.

    CAS  PubMed  Google Scholar 

  119. Shimizu C, Rambaud C, Cheron G, Rouzioux C, Lozinski GM, Rao A, Stanway G, Krous HF, Burns JC. Molecular identification of viruses in sudden infant death associated with myocarditis and pericarditis. Pediatr Infect Dis J. 1995;14(7):584–8.

    Article  CAS  PubMed  Google Scholar 

  120. Satoh T, Kojima M, Ohshima K. Demonstration of the Epstein-Barr genome by the polymerase chain reaction and in situ hybridisation in a patient with viral pericarditis. Br Heart J. 1993;69(6):563–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  121. Dressler W. Effect of respiration on the pericardial friction rub. Am J Cardiol. 1961;7:130–1.

    Article  CAS  PubMed  Google Scholar 

  122. Farringer Jr JL, Carr D. Cardiac tamponade. Ann Surg. 1955;141(4):437–42.

    Article  PubMed  PubMed Central  Google Scholar 

  123. Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation. 2005;112(23):3608–16.

    Article  PubMed  Google Scholar 

  124. Strauss AW, Santa-Maria M, Goldring D. Constrictive pericarditis in children. Am J Dis Child. 1975;129(7):822–6.

    CAS  PubMed  Google Scholar 

  125. Sagrista Sauleda J, Permanyer Miralda G, Soler Soler J. [Diagnosis and management of acute pericardial syndromes]. Rev Esp Cardiol. 2005;58(7):830–41

    Google Scholar 

  126. Spodick DH. The normal and diseased pericardium: current concepts of pericardial physiology, diagnosis and treatment. J Am Coll Cardiol. 1983;1(1):240–51.

    Article  CAS  PubMed  Google Scholar 

  127. Garcia MJ. Constrictive pericarditis versus restrictive cardiomyopathy? J Am Coll Cardiol. 2016;67(17):2061–76.

    Article  PubMed  Google Scholar 

  128. Bonnefoy E, Godon P, Kirkorian G, Fatemi M, Chevalier P, Touboul P. Serum cardiac troponin I and ST-segment elevation in patients with acute pericarditis. Eur Heart J. 2000;21(10):832–6.

    Article  CAS  PubMed  Google Scholar 

  129. Feng D, Glockner J, Kim K, Martinez M, Syed IS, Araoz P, Breen J, Espinosa RE, Sundt T, Schaff HV, Oh JK. Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study. Circulation. 2011;124(17):1830–7.

    Article  CAS  PubMed  Google Scholar 

  130. Khandaker MH, Espinosa RE, Nishimura RA, Sinak LJ, Hayes SN, Melduni RM, Oh JK. Pericardial disease: diagnosis and management. Mayo Clin Proc. 2010;85(6):572–93.

    Article  PubMed  PubMed Central  Google Scholar 

  131. Teh BS, Walsh J, Bell AJ, Walker SJ, Kilpatrick D. Electrical current paths in acute pericarditis. J Electrocardiol. 1993;26(4):291–300.

    Article  CAS  PubMed  Google Scholar 

  132. Lau TK, Civitello AB, Hemandez A, Coulter SA. Cardiac tamponade and electrical alternans. Tex Heart Inst J. 2002;29(1):66–7.

    PubMed  PubMed Central  Google Scholar 

  133. Kahlert P, Katz MA, Buck T, Erbel R. Electrical alternans due to cardiac tamponade. Herz. 2005;30(2):151–2.

    Article  PubMed  Google Scholar 

  134. Imazio M, Adler Y. Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis. Heart Fail Rev. 2013;18(3):355–60.

    Article  CAS  PubMed  Google Scholar 

  135. Imazio M, Cecchi E, Demichelis B, Ierna S, Demarie D, Ghisio A, Pomari F, Coda L, Belli R, Trinchero R. Indicators of poor prognosis of acute pericarditis. Circulation. 2007;115(21):2739–44.

    Article  PubMed  Google Scholar 

  136. Imazio M, Adler Y. Management of pericardial effusion. Eur Heart J. 2013;34(16):1186–97.

    Article  PubMed  Google Scholar 

  137. LeWinter MM. Acute pericarditis. N Engl J Med. 2014;371(25):2410–6.

    Article  PubMed  CAS  Google Scholar 

  138. Adler Y, Charron P, Imazio M, Badano L, Baron-Esquivias G, Bogaert J, Brucato A, Gueret P, Klingel K, Lionis C, Maisch B, Mayosi B, Pavie A, Ristic AD, Sabate Tenas M, Seferovic P, Swedberg K, Tomkowski W, Achenbach S, Agewall S, Al-Attar N, Angel Ferrer J, Arad M, Asteggiano R, Bueno H, Caforio AL, Carerj S, Ceconi C, Evangelista A, Flachskampf F, Giannakoulas G, Gielen S, Habib G, Kolh P, Lambrinou E, Lancellotti P, Lazaros G, Linhart A, Meurin P, Nieman K, Piepoli MF, Price S, Roos-Hesselink J, Roubille F, Ruschitzka F, Sagrista Sauleda J, Sousa-Uva M, Uwe Voigt J, Luis Zamorano J; European Society of Cardiology (ESC). 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921–64.

    Google Scholar 

  139. Burch GE, Tsui CY. Evolution of coxsackie viral valvular and mural endocarditis in mice. Br J Exp Pathol. 1971;52(4):360–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  140. Burch GE, DePasquale NP, Sun SC, Mogabgab WJ, Hale AR. Endocarditis in mice infected with coxsackie virus B4. Science. 1966;151(3709):447–8.

    Article  CAS  PubMed  Google Scholar 

  141. Blumental S, Reynders M, Willems A, Biarent D, Duttman R, Lepage P, Vergison A. Enteroviral infection of a cardiac prosthetic device. Clin Infect Dis. 2011;52(6):710–6.

    Article  PubMed  Google Scholar 

  142. Fournier PE, Charrel R, Raoult D. Viral endocarditis or simple viral disseminated infection? Clin Infect Dis. 2011;53(12):1298; author reply 1299–1300.

    Google Scholar 

  143. Starc TJ, Lipshultz SE, Kaplan S, Easley KA, Bricker JT, Colan SD, Lai WW, Gersony WM, Sopko G, Moodie DS, Schluchter MD. Cardiac complications in children with human immunodeficiency virus infection. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group, National Heart, Lung, and Blood Institute. Pediatrics. 1999;104(2):e14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  144. Lipshultz SE, Chanock S, Sanders SP, Colan SD, Perez-Atayde A, McIntosh K. Cardiovascular manifestations of human immunodeficiency virus infection in infants and children. Am J Cardiol. 1989;63(20):1489–97.

    Article  CAS  PubMed  Google Scholar 

  145. Morse CG, Kovacs JA. Metabolic and skeletal complications of HIV infection: the price of success. JAMA. 2006;296(7):844–54.

    Article  CAS  PubMed  Google Scholar 

  146. Sudano I, Spieker LE, Noll G, Corti R, Weber R, Luscher TF. Cardiovascular disease in HIV infection. Am Heart J. 2006;151(6):1147–55.

    Article  PubMed  Google Scholar 

  147. Lipshultz SE, Easley KA, Orav EJ, Kaplan S, Starc TJ, Bricker JT, Lai WW, Moodie DS, Sopko G, Colan SD. Cardiac dysfunction and mortality in HIV-infected children: the Prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group. Circulation. 2000;102(13):1542–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  148. Herskowitz A, Wu TC, Willoughby SB, Vlahov D, Ansari AA, Beschorner WE, Baughman KL. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol. 1994;24(4):1025–32.

    Article  CAS  PubMed  Google Scholar 

  149. Barbaro G. Cardiovascular manifestations of HIV infection. J R Soc Med. 2001;94(8):384–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  150. Riddler SA, Smit E, Cole SR, Li R, Chmiel JS, Dobs A, Palella F, Visscher B, Evans R, Kingsley LA. Impact of HIV infection and HAART on serum lipids in men. JAMA. 2003;289(22):2978–82.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Children’s Mercy Hospital and Clinics, University of Missouri-Kansas City, 2401 Gillham Road, Kansas City, MO, 64108, USA

    Brian F. Birnbaum M.D.

  2. St. Louis Children’s Hospital, Washington University in St. Louis, St. Louis, MO, USA

    Charles E. Canter M.D.

Authors
  1. Brian F. Birnbaum M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charles E. Canter M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brian F. Birnbaum M.D. .

Editor information

Editors and Affiliations

  1. Department of Paediatrics and Child Health, University of Pretoria, School of Medicine, Pretoria, ZA, South Africa

    Robin J. Green

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Birnbaum, B.F., Canter, C.E. (2017). Viral Cardiac Infections. In: Green, R. (eds) Viral Infections in Children, Volume II. Springer, Cham. https://doi.org/10.1007/978-3-319-54093-1_5

Download citation

Publish with us

Policies and ethics

Search

Navigation